Ohio Public Employees Retirement System (OPERS)’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
Ohio Public Employees Retirement System (OPERS)'s ARCT Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) increased its Arcturus Therapeutics (ARCT) stake by 345% in Q2 2026, buying an estimated $208K and bringing the position to 34,050 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.
Ohio Public Employees Retirement System (OPERS) first reported a position in ARCT in Q4 2023 and has held it in 9 quarters since. The position peaked at $240K in Q2 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 34,050 shares of Arcturus Therapeutics worth $229K as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) bought 26,399 Arcturus Therapeutics shares in Q2 2026, an estimated $208K.
- Arcturus Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1634 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Arcturus Therapeutics in Q4 2023 and has held it in 9 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Arcturus Therapeutics position peaked at $240K in Q2 2025.
- 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.